Epidermal growth factor and amphiregulin up-regulate matrix metalloproteinase-9 (MMP-9) in human breast cancer cells

International Journal of Cancer

Volumn 70, Issue 6, 1997, Pages 722-726

  Kondapaka, Sudhir B ^a   Fridman, Rafael ^a   Reddy, Kaladhar B ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 BROMOANILINO) 6,7 DIMETHOXYQUINAZOLINE; AMPHIREGULIN; ENZYME INHIBITOR; EPIDERMAL GROWTH FACTOR; METALLOPROTEINASE; NEU DIFFERENTIATION FACTOR;

ARTICLE; BREAST CANCER; CANCER CELL; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME RELEASE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL DIVISION; COLLAGENASES; ENZYME INHIBITORS; EPIDERMAL GROWTH FACTOR; GELATINASES; GLYCOPROTEINS; GROWTH SUBSTANCES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0030888746     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970317)70:6<722::AID-IJC15>3.0.CO;2-B     Document Type: Article

References (36)

1. ANGEL, P., BAUMANN, I., STEIN, B., DELIUS, H., RAHMSDORF, H.J. and HERRUCH, P., 12-o-Tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5′-flanking region. Mol. Cell Biol., 7, 2256-2266 (1987).
2. BAE, S.N., ARAND, G., AZZAM, H., PAVASANT, P., TORRI, J., FRANDSEN, T.L. and THOMPSON, E., Molecular and cellular analysis of basement membrane invasion by human breast cancer cells in Matrigel-based in vitro assays. Breast Cancer Res. Treat., 24, 241-255 (1993).
3. BROWN, P.D., LEVY, A.T., MARGUUES, I.M.K., LIOTTA, L.A. and STETLER-STEVENSON, W.G., Independent expression and cellular processing of the 72-kDa type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res., 50, 6184-6191 (1990).
4. CIARDIEELO, F. and 13 OTHERS, Transforming growth factor-α expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene. and overexpression of the transforming growth factor-α complementary DNA leads to transformation. Cell Growth Differentiation, 1, 407-420 (1990).
5. CIARDIELEO, F., DONO, R., KIM, N., PERSICO, M.G. and SALOMON, D.S., Expression of cripto, a novel gene of the epidermal growth factor gene family, leads to in vitro transformation of a normal mouse mammary epithelial cell line. Cancer Res., 51, 1051-1054 (1991).
6. CONCA, W., KAPLAN, P.B. and KRANE, S.M., Increases in levels of procollagenase messenger RNA in cultured fibroblasts induced by human recombinant interleukin 1β or serum follow c-jun expression and are dependent on new protein synthesis. J. clin. Invest., 83, 1753-1755 (1989).
7. DAVIDSON, N.E., GELMAN, E.P., LIPPMAN, M.E. and DICKSON, R.B., Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative breast cancer cell lines. Mol. Endocrinol., 1, 216-223 (1987).
8. DAVIES, B., MILES, D.W., HAPPERFIELD, L.C., NAYLOR, M.S., BOBROW, L.G., RUBENS, R.D. and BALKWILL, F., Activity of type IV collagenases in benign and malignant breast disease. Brit. J. Cancer, 67, 1126-1131 (1993).
9. DOYLE, H.J. and BISHOP, J.M., Torso, a receptor tyrosine kinase required for embryonic pattern formation, shares substrates with the sevenless and EGFR pathways in Drosophila. Genes Develop., 7, 633-646 (1993).
10. FRIDMAN, R., TOTH, M., PENA, D. and MOBASHERY, S., Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res., 55, 2548-2555 (1995).
11. FRY, D.W., KRAKER, A.J., MCMICHAEL, A., AMBROSO, L.A., NELSON, J.M., LEOPOLD, W.R., CONNORS, R.W. and BRIDGES, A.J., A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. Science, 265, 1093-1095 (1994).
12. HELDIN, C.H., BETSHOLTZ, L., CLAESSON-WELSH, L. and WESTERMARK, B., Subversion of growth regulatory pathways in malignant transformation. Biochem. biophys. Acta. 907, 219-244 (1987).
13. HIRATA, Y., MOORE, G.W., BERTAGNA, C. and ORTH, D.N., Plasma concentration of immunoreactive human epidermal growth factor (urogastrone) in man. J. clin. Endocrinol. Metab., 40, 440-444 (1980).
14. HIRATA, Y. and ORTH, D.N., Epidermal growth factor (urogastrone) in human tissues. J. clin. Endocrinol. Metab., 48, 667-671 (1979).
15. HYUGA, S., NISHIKAWA, Y., SAKATA, K., TANAKA, H., YAMAGATA, S., SUGITA, K., SAGA, S., MATSUYAMA, M. and SHIMIZU, S., Autocrine factor enhancing the secretion of Mr 95,000 gelatinase (MMP-9) in serum-free medium conditioned with murine metastatic colon carcinoma cells. Cancer Res., 54, 3611-3616 (1994).
16. JHAPPAN, C., STAHLE, C., HARKINS, R.N., FAUSTO, N., SMITH, G.H. and MERLINO, G.T., TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell, 61, 1137-1146 (1990).
17. KHAZAIE, K., SCHIRRMACHER, V. and LICHTNER, R.B., EGF receptor in neoplasia and metastasis. Cancer Metastasis Rev., 12, 255-274 (1993).
18. KOKAI, Y., DOBASHI, K., MYERS, J.N., NOWELL, P.C. and GREENE, M.I., Phosphorylation process induced by epidermal growth factor alters cellular and oncogenic neu gene products. Proc. nat. Acad. Sci. (Wash.), 85, 5389-5393 (1988).
19. KOKAI, Y., MYERS, J.N., WADA, T., BROWN, V.I., LEVEA, CM., DAVIS, J.G., DOBASHI, K. and GREENE, M.I., Synergistic interaction of p185 c-neu and EGF receptor leads to transformation of rodent fibroblasts. Cell, 58, 287-292 (1989).
20. LISA, J.M. and LAURIE, H.G., Receptor tyrosine kinase specificity in the mediation of keratinocyte motility and invasive potential [abstract]. Proteases and Protease inhibitors. AACR Special Conference, p. B-22 (1996).
21. MATSUI, Y., HALTER, S.A., HOLT, J.T., HOGAN, B.L.M. and COFFEY, R.J., Development of mammary hyperplasia and neoplasia in MMTV-TGFα transgemc mice. Cell, 61, 1147-1155 (1990).
22. MONTEAGUDO, C., MERINO, M.J., SAN-JUAN, J., LIOTTA, L.A. and STETLER-STEVENSON, W.G., Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue. Amer. J. Pathol., 136, 585-592 (1990).
23. NORMANNO, N., CIARDIELLO, F., BRANDT, R. and SALOMON, D.S., Epidermal growth factor-related peptides in the pathogenesis of human breast cancer. Breast Cancer Res. Treat., 29, 11-27 (1994).
24. OKADA, A., BELLOCQ, J.P., ROUYER, N., CHENARD, M.P., RIO, M.C., CHAMBON, P. and BASSET, P., Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cell of human colon, breast and head and neck carcinomas. Proc. nat. Acad Sci. (Wash.), 92, 2730-2734 (1995).
25. OSBORNE, C.K. and ARTEAGA, C.L., Autocrine and paracrine growth regulation of breast cancer: clinical implication. Breast Cancer Res. Treat., 15, 3-11 (1990).
26. OVERALL, C.M., WRANA, J.L. and SODEK, J., Independent regulation of collagenase. 72 kDa progelatinase and metalloproteinase inhibitor expression in human fibroblasts by transforming growth factor-β. J. biol. Chem., 264, 1860-1869 (1989).
27. PELES, E. and YARDEN, Y., Neu and its ligands: from an oncogene to neural factor. BioEssays, 15, 815-824 (1993).
28. PLOWMAN, G.D., CULOUSCOU, J.M., WHITNEY, G.S., GREEN, J.M., CARLTON, G.W., FOY, L., NEUBAUER, M.G. and SHOYAB, M., Ligand specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family. Proc. nat. Acad. Sci. (Wash.), 90, 1746-1750 (1993).
29. POLETTE, M., CLAVEL, C., COCKETT, M., BENTZMANN, S.G., MURPHY, G. and BIREMBAUT, P., Detection and localization of m-RNA's encoding matrix metalloproteinases and their inhibitors in human breast pathology. Invasion Metastasis, 13, 31-37 (1993).
30. POULSOM, R., PIGNATELLI, M., STETLER-STEVENSON, W.G., LIOTTA, L.A., WRIGHT, P.A., JEFFERY, R.E., LONGCROFT, J.M., ROGERS, L. and STAMP, G.W.H., Stromal expression of 72kDa type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Amer. J. Pathol., 141, 389-396 (1992).
31. RAJKUMAR, T. and GULLICK, W.J., The type I growth factor receptors in human breast cancer. Breast Cancer Res. Treat., 29, 3-9 (1994).
32. REDDY, K.B., MANGOLD, G.L., TANDON, A.K., YONEDA, T., MUNDY, G.R., ZILBERSTEIN, A. and OSBORNE, C.K., Inhibition of breast cancer cell growth in vitro by tyrosine kinase inhibitor. Cancer Res., 52, 3636-3641 (1992).
33. REDDY, K.B., YEE, D., HILSENBECK, S.G., COFFEY, R.J. and OSBORNE, C.K., Inhibition of estrogen-induced breast cancer cell proliferation by reduction in autocrine transforming growth factor alpha expression. Cell Growth Differentiation. 5, 1275-1282 (1994).
34. SAINSBURY, J.R.C., FARNDON, J.R., NEEDHAM, G.K., MALCOLM, A.J. and HARRIS, A.L., Epidermal growth factor receptor status as a predictor of relapse and death from breast cancer. Lancet, i, 1398-1402 (1987).
35. SATO, H. and SEIKI, M., Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene, 8, 395-405 (1993).
36. WILHELM, S.M., COLLIER, I.E., MARMER, B.L., EISEN, A.Z., GRANT, G.A. and GOLDBERG, G.I., SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J. biol. Chem., 264, 17213-17221 (1989).